Dihydroartemisinin for PCOS: A Phase 2 Trial
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests if dihydroartemisinin (a medicine derived from a plant) can help women with PCOS. It may improve hormone balance and menstrual cycles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with PCOS, meaning you have irregular periods and high levels of male hormones or excess hair growth.
- Your body mass index (BMI) must be between 18.5 and 28.
- You must have a negative pregnancy test and not plan to become pregnant for the next 6 months.
- You cannot have liver, kidney, or blood disorders (like anemia or low white blood cells).
- You cannot have other hormonal diseases, diabetes, heart disease, or cancer.
- You must stop taking certain medications (like birth control, metformin, or hormone treatments) for at least 2 months before the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests three treatments—birth control pills, progesterone, and inositol—to see which best helps regulate menstrual cycles in women with PCOS. It aims to find an effective option that is safe and easy to use.
This study tests if a specific diet can help women with PCOS who are overweight. It looks at weight, hormone balance, and menstrual health over several months.
This study looks at fertility in women with polycystic ovary syndrome (PCOS) compared to women without it, to better understand how PCOS affects fertility. If you have PCOS or have normal hormones and metabolism, and you were part of a previous study called METABOPK, you may be able to join.
This trial tests adding quercetin or alpha lipoic acid to standard PCOS care to see if they improve symptoms and blood markers. It may help women who have irregular periods or signs of excess androgens like acne.
This study looks at hormone levels and metabolism in people who may have polycystic ovary syndrome (PCOS). It aims to better understand why PCOS happens, which could help improve future diagnosis and treatment.
This trial tests if sitagliptin or BeiDouGen capsule can improve pregnancy outcomes in women with PCOS. It aims to help those planning to conceive or struggling with infertility.
Hear when a new Polycystic Ovary Syndrome (PCOS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.